Thalamic Projection Fiber Integrity in de novo Parkinson Disease

References

1. 1.↵
   1. Braak H,
   2. Del Tredici K,
   3. Rüb U,
   4. et al

   . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197–211

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Hodaie M,
   2. Neimat JS,
   3. Lozano AM

   . The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies. Neurosurgery 2007;60:17–28

   PubMedWeb of Science
3. 3.↵
   1. Blumenfeld H

   . Neuroanatomy through Clinical Cases. Sunderland, Massachusetts: Sinauer Associates; 2002
4. 4.↵
   1. Owen AM,
   2. Doyon J,
   3. Dagher A,
   4. et al

   . Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 1998;121:949–65

   Abstract/FREE Full Text
5. 5.↵
   1. Braak H,
   2. Braak E

   . Pathoanatomy of Parkinson's disease. J Neurol 2000;247:3–10

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Emre M

   . What causes mental dysfunction in Parkinson's disease? Mov Disord 2003;18:S63–71

   CrossRef
7. 7.↵
   1. Nobili F,
   2. Campus C,
   3. Arnaldi D,
   4. et al

   . Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT Study. Mov Disord 2010;25:35–43

   PubMed
8. 8.↵
   1. McKeown MJ,
   2. Uthama A,
   3. Abugharbieh R,
   4. et al

   . Shape (but not volume) changes in the thalami in Parkinson disease. BMC Neurol 2008;8:8

   CrossRefPubMed
9. 9.↵
   1. Prodoehl J,
   2. Spraker M,
   3. Corcos D,
   4. et al

   . Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease. Mov Disord 2010;25:2035–43

   CrossRefPubMed
10. 10.↵
    1. Halliday GM

    . Thalamic changes in Parkinson's disease. Parkinsonism & Relat Disord 2009;15:S152

    PubMed
11. 11.↵
    1. Rüb U,
    2. Del Tredici K,
    3. Schultz C,
    4. et al

    . Parkinson's disease: the thalamic components of the limbic loop are severely impaired by a-synuclein immunopositive inclusion body pathology. Neurobiol Aging 2002;23:245–54

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Planetta PJ,
    2. Prodoehl J,
    3. Corcos DM,
    4. et al

    . Use of MRI to monitor Parkinson's disease. Neurodegener Dis Manag 2011;1:67–77

    CrossRef
13. 13.↵
    1. Mahlknecht P,
    2. Hotter A,
    3. Hussl A,
    4. et al

    . Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis 2010;7:300–18

    CrossRefPubMed
14. 14.↵
    1. Vaillancourt D,
    2. Spraker M,
    3. Prodoehl J,
    4. et al

    . High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009;72:1378–84

    CrossRef
15. 15.↵
    1. Péran P,
    2. Cherubini A,
    3. Assogna F,
    4. et al

    . Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 2010;133:3423–33

    Abstract/FREE Full Text
16. 16.↵
    1. Zhan W,
    2. Kang GA,
    3. Glass GA,
    4. et al

    . Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord 2012;27:90–97

    CrossRefPubMed
17. 17.↵
    1. Du G,
    2. Lewis MM,
    3. Styner M,
    4. et al

    . Combined r2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord 2011;26:1627–32

    CrossRefPubMed
18. 18.↵
    1. Basser PJ,
    2. Mattiello J,
    3. Lebihan D

    . MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66:259–67

    PubMedWeb of Science
19. 19.↵
    1. Minati L,
    2. Banasik T,
    3. Brzezinski J,
    4. et al

    . Elevating tensor rank increases anisotropy in brain areas associated with intra-voxel orientational heterogeneity (IVOH): a generalised DTI (GDTI) study. NMR Biomed 2008;21:2–14

    CrossRefPubMed
20. 20.↵
    1. Boska MD,
    2. Hasan KM,
    3. Kibuule D,
    4. et al

    . Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease. Neurobiol Dis 2007;26:590–96

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Brooks D,
    2. Halliday GM

    . Intralaminar nuclei of the thalamus in Lewy body diseases. Brain Res Bull 2009;78:97–104

    CrossRefPubMed
22. 22.↵
    1. Henderson JM,
    2. Carpenter K,
    3. Cartwright H,
    4. et al

    . Degeneration of the centre median-parafascicular complex in Parkinson's disease. Ann Neurol 2000;47:345–52

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Henderson JM,
    2. Carpenter K,
    3. Cartwright H,
    4. et al

    . Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000;123:1410–21

    Abstract/FREE Full Text
24. 24.↵
    1. Chan LL,
    2. Rumpel H,
    3. Yap K,
    4. et al

    . Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:1383–86

    Abstract/FREE Full Text
25. 25.↵
    1. Li W,
    2. Liu J,
    3. Skidmore F,
    4. et al

    . White matter microstructure changes in the thalamus in Parkinson disease with depression: a diffusion tensor MR imaging study. AJNR Am J Neuroradiol 2010;31:1861–66

    Abstract/FREE Full Text
26. 26.↵
    1. Little DM,
    2. Kraus MF,
    3. Joseph J,
    4. et al

    . Thalamic integrity underlies executive dysfunction in traumatic brain injury. Neurology 2010;74:558–64

    CrossRef
27. 27.↵
    1. Hughes A,
    2. Daniel S,
    3. Kilford L,
    4. et al

    . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–84

    Abstract/FREE Full Text
28. 28.↵
    1. Hughes AJ,
    2. Ben-Shlomo Y,
    3. Daniel SE,
    4. et al

    . What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992. Neurology 2001;57:S34–38
29. 29.↵
    1. Zhou X,
    2. Naier J,
    3. Reynolds H

    . Method to reduce eddy current effects in diffusion-weighted echo planar imaging. United States Patent, 5 1999;864:233
30. 30.↵
    1. Jiang H,
    2. van Zijl PC,
    3. Kim J,
    4. et al

    . DTIStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed 2006;81:106–16

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Cox RW

    . AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162–73

    CrossRefPubMedWeb of Science
32. 32.↵
    1. DeBoy CA,
    2. Zhang J,
    3. Dike S,
    4. et al

    . High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain 2007;130:2199–210

    Abstract/FREE Full Text
33. 33.↵
    1. Budde MD,
    2. Janes L,
    3. Gold E,
    4. et al

    . The contribution of gliosis to diffusion tensor anisotropy and tractography following traumatic brain injury: validation in the rat using Fourier analysis of stained tissue sections. Brain 2011;134:2248–60

    Abstract/FREE Full Text
34. 34.↵
    1. Wimberger DM,
    2. Roberts TP,
    3. Barkovich AJ,
    4. et al

    . Identification of “premyelination” by diffusion-weighted MRI. J Comput Assist Tomogr 1995;19:28–33

    PubMedWeb of Science
35. 35.↵
    1. Klingberg T,
    2. Vaidya CJ,
    3. Gabrieli JD,
    4. et al

    . Myelination and organization of the frontal white matter in children: a diffusion tensor MRI study. Neuroreport 1999;10:2817–21

    PubMedWeb of Science
36. 36.↵
    1. Zhang D,
    2. Snyder AZ,
    3. Shimony JS,
    4. et al

    . Noninvasive functional and structural connectivity mapping of the human thalamocortical system. Cereb Cortex 2010;20:1187–94

    Abstract/FREE Full Text
37. 37.↵
    1. Metzger CD,
    2. Eckert U,
    3. Steiner J,
    4. et al

    . High field FMRI reveals thalamocortical integration of segregated cognitive and emotional processing in mediodorsal and intralaminar thalamic nuclei. Front Neuroanat 2010;4:138

    PubMed
38. 38.↵
    1. Schmahmann JD

    . Vascular syndromes of the thalamus. Stroke 2003;34:2264–78

    Abstract/FREE Full Text
39. 39.↵
    1. Klein JC,
    2. Rushworth MF,
    3. Behrens TE,
    4. et al

    . Topography of connections between human prefrontal cortex and mediodorsal thalamus studied with diffusion tractography. Neuroimage 2010;51:555–64

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Behrens TE,
    2. Johansen-Berg H,
    3. Woolrich MW,
    4. et al

    . Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 2003;6:750–57

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Jahanshahi M,
    2. Jenkins IH,
    3. Brown RG,
    4. et al

    . Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995;118:913–33

    Abstract/FREE Full Text
42. 42.↵
    1. Spraker M,
    2. Prodoehl J,
    3. Corcos D,
    4. et al

    . Basal ganglia hypoactivity during grip force in drug naïve Parkinson's disease. Hum Brain Mapp 2010;31:1928–41

    CrossRefPubMed
43. 43.↵
    1. Carrera E,
    2. Bogousslavsky J

    . The thalamus and behavior: effects of anatomically distinct strokes. Neurology 2006;66:1817–23

    CrossRef
44. 44.↵
    1. Yoshikawa K,
    2. Nakata Y,
    3. Yamada K,
    4. et al

    . Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004;75:481–84

    Abstract/FREE Full Text
45. 45.↵
    1. Gattellaro G,
    2. Minati L,
    3. Grisoli M,
    4. et al

    . White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2009;30:1222–26

    Abstract/FREE Full Text
46. 46.↵
    1. Chaudhuri KR,
    2. Healy DG,
    3. Schapira AH,
    4. et al

    . Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235–45

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Kwon HG,
    2. Hong JH,
    3. Hong CP,
    4. et al

    . Dentatorubrothalamic tract in human brain: diffusion tensor tractography study. Neuroradiology 2011;53:787–91

    CrossRefPubMed
48. 48.↵
    1. Nicoletti G,
    2. Manners D,
    3. Novellino F,
    4. et al

    . Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. Neurology 2010;74:988–94

    CrossRef
49. 49.↵
    1. Leh SE,
    2. Chakravarty MM,
    3. Ptito A

    . The connectivity of the human pulvinar: a diffusion tensor imaging tractography study. Int J Biomed Imaging 2008:78953
50. 50.↵
    1. Arend I,
    2. Machado L,
    3. Ward R,
    4. et al

    . The role of the human pulvinar in visual attention and action: evidence from temporal-order judgment, saccade decision, and antisaccade tasks. Prog Brain Res 2008;171:475–83

    CrossRefPubMed
51. 51.↵
    1. Van der Werf YD,
    2. Witter MP,
    3. Groenewegen HJ

    . The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev 2002;39:107–40

    CrossRefPubMed